Search

everythinglearnresearchcommunity

for

Search:↓

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Baricitinib helps treat severe hair loss in people over 65.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Oil A formulation with Baricitinib shows promise for treating alopecia areata by promoting hair growth.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Sonidegib and vismodegib have different side effects and reporting patterns.

Baricitinib may effectively treat nail changes in alopecia areata.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

The formulated gel is a promising treatment for alopecia areata.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Osthole inhibits the TRPV3 channel by binding to specific sites, potentially aiding drug development for skin diseases and cancers.

Topical tacrolimus is safe and effective for skin conditions, but oral tacrolimus has serious side effects.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

TrichoSol™ effectively stabilizes various hair treatment ingredients for different durations.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Topical clobetasol propionate 0.05% ointment is more effective in promoting hair regrowth in patients with alopecia areata than topical tacrolimus 0.1% ointment.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.